To this aim, RES-CRC-SCs were treated or not with the CHK1 inhibitor prexasertib together with inhibitors of ATR (VE-821), ATM (KU-60019), DNA-PK (NU-7026), MRE11 (mirin), and RAD51 (B02). Here, ATM is linked to colorectal carcinoma.